Skip to main content
Depression is more widespread than ever in the United States, according to a new study from Gallup, showing that 18% of adults are depressed (or receiving depression treatment for depression) – an increase in 7 percentage points since 2015. 
A Danish cohort study has shown a deadly association between depression and rheumatoid arthritis (RA).   Using data from the national Danish rheumatologic database, DANBIO, they identified incident RA patients (between 2008 to 2018) and five random non-RA comparators. Drug use (antidepressants), socioeconomic status, mortality, and cause of death were identified from other registers. 
Zoster Management and Vaccination
Bringing pivotal clinical trials to you: announcing RheumNow’s Poster Hall, featuring previously presented, sponsor-ge

Dr. John Cush RheumNow

3 years 2 months ago
Bringing pivotal clinical trials to you: announcing RheumNow’s Poster Hall, featuring previously presented, sponsor-generated clinical trial posters designed to educate and inform. https://t.co/2hqKVhtzbv https://t.co/2dTvdU2A9t
Biosimilars Match Biologic Originators in RA

A JAMA review shows that biosimilars of adalimumab, infliximab, and etaner

Dr. John Cush RheumNow

3 years 2 months ago
Biosimilars Match Biologic Originators in RA A JAMA review shows that biosimilars of adalimumab, infliximab, and etanercept were associated w/clinically equivalent treatment effects compared with their ref biologics for treatment of RA. https://t.co/MqxqpzzpiJ https://t.co/Eh98wBUHlj
Time to Risk Stratify Methotrexate Lab Monitoring?

A longitudinal cohort analysis has developed a prognostic model tha

Dr. John Cush RheumNow

3 years 2 months ago
Time to Risk Stratify Methotrexate Lab Monitoring? A longitudinal cohort analysis has developed a prognostic model that informs a risk stratified approach to monitoring blood tests during long term methotrexate (MTX) therapy. https://t.co/lpRhRYg7dd https://t.co/kU2gs3Oljg
Metanalysis of 62 RCTs, 16 LTEs of JAKi, placebo, TNFi, & MTX Rx pts shows that malignancy incidence rate =1.15-1.26

Dr. John Cush RheumNow

3 years 2 months ago
Metanalysis of 62 RCTs, 16 LTEs of JAKi, placebo, TNFi, & MTX Rx pts shows that malignancy incidence rate =1.15-1.26/100 Pt-Yrs. Neoplasia risk w/ JAKi = PBO or MTX risk (IRR 0.71 & 0.77); but JAKi CA risk if compared to TNFi (IRR 1.50;1.16 to 1.94) https://t.co/uOgPFlJ2z1 https://t.co/Ynh6SMQdke
#RA pts at increased risk of gastroparesis (GP). From 2012–2014 National Inpatient Sample database; among 1.5 million

Dr. John Cush RheumNow

3 years 2 months ago
#RA pts at increased risk of gastroparesis (GP). From 2012–2014 National Inpatient Sample database; among 1.5 million RA, 1070 hospitalized for GP (OR 1.36; 1.24 to 1.49,P< 0.0001). GP risk incr by aging up to 65 yrs, DM, RA, income 26-75th percentiles https://t.co/2U4vSTtxen https://t.co/ub4z4ntcNk
Combined cranial and large vessel ultrasound and PET/CT provided excellent accuracy for the diagnosis of giant cell arteritis (GCA).
EULAR Offers Tips on Psoriasis Progression to PsA
  • MedPage Today
Clinicians treating patients with psoriasis should be on the lookout for certain signs that joint involvement is likely to develop, according to a new "points to consider" documentopens in a new tab or window from the European Alliance of Associations for Rheumatology (EULAR).
TNR- Rheumatoid Arthritis - Decisive Therapeutics

Replay of this RA pod from RheumNow Live 2023, recorded on March 18,

Dr. John Cush RheumNow

3 years 2 months ago
TNR- Rheumatoid Arthritis - Decisive Therapeutics Replay of this RA pod from RheumNow Live 2023, recorded on March 18, 2023 https://t.co/RyyKQFDrT5 https://t.co/ZHjJRzHJ0Q
RheumNow Eular 2023 Daily Recap Series - Day3

June 2, 2023 RheumNow faculty and reporters provide a daily recap of con

Dr. John Cush RheumNow

3 years 2 months ago
RheumNow Eular 2023 Daily Recap Series - Day3 June 2, 2023 RheumNow faculty and reporters provide a daily recap of conference content coverage. https://t.co/4aHy2uJOc6 https://t.co/zOBMX7sgXl
Update on CAR T-Cell Therapy in SLE &amp; Autoimmune Diseases

Dr. Peter Nash ( @drpnash ) reporting from EULAR 2023 in

Dr. John Cush RheumNow

3 years 2 months ago
Update on CAR T-Cell Therapy in SLE & Autoimmune Diseases Dr. Peter Nash ( @drpnash ) reporting from EULAR 2023 in Milan, Italy. https://t.co/UNXLD5GVKi https://t.co/q8OAexChBN
×